ERBB2 and breast cancer: We further analyzed consecutive sections of a triple-negative (estrogen/progesterone receptor and HER2-negative) breast cancer sample to discover how heterogeneous tumor subclones exist in the three-dimensional space of the tissue and to demonstrate how PHLI-seq can be an empowering tool to bridge genomics to histopathology (Fig. 5a).